Project Details
Description
IM119-014: A 12-Week, Randomized, Semi Double-Blinded Study Evaluating the Effects of Daily Oral High-Dose Atorvastatin or BMS-582949 on Atherosclerotic Plaque Inflammation as Determined by FDG-PET in High Risk Atherosclerotic Patients
| Status | Finished |
|---|---|
| Effective start/end date | 5/12/09 → 5/31/11 |
Funding
- BRISTOL-MYERS SQUIBB PHARM RES
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.